Dr. Anil Prasad Bhatt brings over 15 years of nephrology excellence and 2,500+ supervised kidney transplants across Delhi's premier hospitals. From evaluation to lifelong post-transplant care, receive world-class treatment at every stage.
A kidney transplant is a surgical procedure in which a healthy kidney from a living or deceased donor is placed into a patient whose kidneys have permanently ceased to function. It remains the gold-standard treatment for end-stage renal disease (ESRD), offering patients a dramatically improved quality of life, freedom from dialysis, and significantly longer survival compared to remaining on maintenance dialysis alone.
Delhi has established itself as one of the foremost centres for kidney transplantation in South Asia. The city is home to AIIMS, Safdarjung Hospital, and an extensive network of private super-speciality hospitals that perform hundreds of renal transplants every year. With NABH-accredited facilities, cutting-edge immunology laboratories, and a deep bench of fellowship-trained transplant nephrologists and urological surgeons, Delhi offers patients the full spectrum of transplant care — from the initial workup and HLA crossmatch testing to complex ABO-incompatible transplants and long-term immunosuppression management.
Dr. Anil Prasad Bhatt has been an integral part of this transplant ecosystem for over fifteen years. Trained at AIIMS with a DM in Nephrology and subsequently elected Fellow of the Royal College of Physicians (London), he combines rigorous academic grounding with extensive hands-on experience. Having supervised more than 2,500 kidney transplants across Max Patparganj, Holy Family Okhla, Mahanandan Greater Noida, and the Renacare dialysis network, Dr. Bhatt provides continuity of care from the moment a patient is diagnosed with chronic kidney disease through the decades that follow a successful transplant.
Patients are typically evaluated for transplantation when their estimated glomerular filtration rate (eGFR) falls below 20 mL/min/1.73 m² — Stage 4 or Stage 5 CKD. At this point, the kidneys retain less than 15–20 percent of their normal filtering capacity, and symptoms such as severe fatigue, persistent nausea, fluid overload, and electrolyte imbalances become increasingly difficult to manage with medication alone.
Common underlying causes that lead to transplant include diabetic nephropathy (the single largest contributor in India), chronic glomerulonephritis, hypertensive nephrosclerosis, polycystic kidney disease, and IgA nephropathy. Early referral to a transplant nephrologist — ideally while the patient still has some residual kidney function — allows time for thorough donor evaluation, pre-emptive transplantation (before dialysis becomes necessary), and optimal surgical planning.
The landscape of kidney transplantation has expanded considerably over the past decade. Delhi's leading hospitals now routinely perform transplant procedures that were once considered too complex or high-risk. Dr. Bhatt's practice covers the full range of transplant modalities, ensuring every eligible patient has a pathway to a functioning graft.
A kidney from a genetically or emotionally related living donor — a parent, sibling, spouse, or close family member. Living donor transplants account for the majority of procedures in India and offer the best long-term graft survival rates. Planned surgery allows optimal timing, thorough donor evaluation, and minimal cold ischaemia time. Dr. Bhatt works closely with families to assess donor fitness, manage expectations, and ensure transparent, ethical consent under the Transplantation of Human Organs Act (THOA).
When no suitable living donor is available, patients are placed on the regional organ waiting list maintained by NOTTO (National Organ and Tissue Transplant Organisation). A kidney from a brain-dead or cardiac-death donor is allocated based on HLA matching, waiting time, and medical urgency. Although wait times in Delhi can range from two to five years, Dr. Bhatt guides patients through registration, maintains them optimally on dialysis, and ensures they are transplant-ready the moment a suitable organ becomes available.
Advances in desensitisation protocols now allow transplantation even when the donor and recipient have incompatible blood groups. Using plasmapheresis, rituximab, and targeted immunoadsorption, Dr. Bhatt and his teams at Max and Holy Family have successfully executed ABO-incompatible transplants, significantly expanding the pool of potential donors for patients who would otherwise face years on the waiting list.
When a willing donor is medically incompatible with their intended recipient, paired kidney exchange (swap transplant) offers a solution. Two or more donor-recipient pairs are matched such that each donor gives a kidney to the other pair's recipient. This programme, supported by NOTTO and increasingly adopted across Delhi hospitals, eliminates blood-group and crossmatch barriers without the need for aggressive desensitisation therapy.
A pre-emptive transplant is performed before the patient requires dialysis — typically at eGFR below 15–20 mL/min. Multiple studies demonstrate superior graft and patient survival with pre-emptive transplantation. Dr. Bhatt actively encourages early referral and evaluation, helping patients avoid the vascular access complications, infection risks, and quality-of-life burden associated with dialysis initiation.
For patients whose first transplant has failed — due to chronic allograft nephropathy, recurrent disease, or non-adherence-related rejection — a second (or even third) transplant remains a viable option. Re-transplantation carries higher immunological risk due to pre-formed antibodies, but with careful crossmatch testing, virtual crossmatch protocols, and tailored immunosuppression, outcomes at experienced centres in Delhi remain excellent. Dr. Bhatt has managed numerous re-transplant cases throughout his career.
One of the most common concerns for patients and families exploring kidney transplant in Delhi is the cost. The total expenditure varies significantly depending on the type of hospital (government versus private), the complexity of the case, the duration of post-operative ICU stay, and whether desensitisation therapy or special immunosuppressive protocols are required.
Dr. Bhatt believes in complete financial transparency. During the initial consultation, his team provides a detailed cost estimate covering surgery, hospitalisation, medications, and follow-up — so there are no unexpected bills. He also assists eligible patients in applying for government schemes such as Ayushman Bharat (PM-JAY) and state-level health insurance programmes that can substantially offset the financial burden.
| Component | Government Hospital | Private Hospital |
|---|---|---|
| Total Transplant Surgery Package | ₹4,00,000 – ₹8,00,000 | ₹10,00,000 – ₹25,00,000 |
| Pre-Transplant Evaluation (Donor + Recipient) | ₹30,000 – ₹60,000 | ₹80,000 – ₹1,50,000 |
| HLA Typing & Crossmatch Testing | ₹15,000 – ₹25,000 | ₹25,000 – ₹50,000 |
| Surgery & Anaesthesia | ₹1,50,000 – ₹3,00,000 | ₹4,00,000 – ₹8,00,000 |
| ICU & Hospitalisation (7–14 days) | ₹50,000 – ₹1,50,000 | ₹2,00,000 – ₹6,00,000 |
| Immunosuppressive Medications (Year 1) | ₹1,00,000 – ₹2,00,000 | ₹1,50,000 – ₹3,50,000 |
| Post-Transplant Follow-Up (Year 1) | ₹20,000 – ₹40,000 | ₹40,000 – ₹1,00,000 |
| ABO-Incompatible Add-On (if applicable) | ₹1,00,000 – ₹2,00,000 | ₹2,00,000 – ₹5,00,000 |
Several schemes can help patients manage transplant costs in Delhi:
Dr. Bhatt's team assists with insurance pre-authorisation and scheme applications as part of the transplant coordination process, ensuring no eligible patient misses out on available support.
Not every patient with kidney failure is immediately suitable for transplantation. A thorough pre-transplant evaluation — typically spanning four to six weeks — assesses both the recipient and the potential donor to ensure the best possible outcomes and minimise surgical and immunological risk.
The recipient workup is designed to identify any medical conditions that might complicate surgery, increase the risk of post-transplant infection, or reduce graft survival. Key components include:
Living donors undergo an equally rigorous — and in some ways more stringent — evaluation, because the ethical imperative is to ensure the donor suffers no long-term harm. This includes:
Absolute contraindications include active untreated infection, active malignancy, severe uncorrectable cardiovascular disease, and active substance abuse. Relative contraindications — such as advanced age, obesity, or prior non-adherence — are evaluated on a case-by-case basis. Dr. Bhatt discusses all findings transparently with patients and families, ensuring informed decision-making at every stage.
A successful surgery is only the beginning. The long-term success of a kidney transplant depends critically on meticulous post-operative care, vigilant immunosuppression management, and a sustained partnership between the patient and their nephrologist. Dr. Bhatt's post-transplant protocol is structured to catch problems early, maintain optimal graft function, and empower patients to live full, active lives.
After surgery, patients are monitored in the transplant ICU for 24–48 hours before transfer to the transplant ward. Key focus areas include:
The first 90 days carry the highest risk of acute rejection, surgical complications (urine leak, lymphocele, renal artery stenosis), and opportunistic infections. Dr. Bhatt schedules weekly clinic visits during this period, with each visit including:
After the initial high-risk period, clinic visits are spaced to monthly, then quarterly, then every four to six months. However, the scope of follow-up broadens to include cardiovascular risk management, metabolic syndrome screening, skin cancer surveillance, and bone health assessment — all conditions for which transplant recipients are at elevated risk due to chronic immunosuppression.
Dr. Bhatt emphasises patient education as the cornerstone of long-term success. His team provides comprehensive guidance on medication timing, dietary modifications (sodium and potassium management, adequate hydration), infection avoidance strategies, exercise, and the critical importance of never stopping immunosuppressive medication without medical guidance.
With adherent patients and contemporary immunosuppression protocols, one-year graft survival for living donor transplants in India exceeds 95 percent, and five-year graft survival is approximately 85–90 percent. Deceased donor transplant outcomes have also improved significantly, with one-year graft survival now above 90 percent at experienced centres. Dr. Bhatt's personal transplant follow-up cohort consistently meets or exceeds these benchmarks, reflecting the rigour of his pre-transplant evaluation and post-transplant monitoring protocols.
Choosing a transplant nephrologist is one of the most consequential decisions a kidney failure patient will make. The nephrologist is not just a pre-surgical consultant — they are the physician who manages the patient's care before, during, and for decades after the transplant. Dr. Bhatt brings a combination of credentials, experience, and patient-centricity that distinguishes his practice.
DM in Nephrology from the All India Institute of Medical Sciences (AIIMS), New Delhi — India's most prestigious medical institution. Fellow of the Royal College of Physicians, London — a distinction conferred on physicians who have demonstrated exceptional clinical expertise and contribution to medicine on an international stage.
Dr. Bhatt practices at four strategically located facilities across Delhi NCR — Max Super Speciality Hospital (Patparganj, East Delhi), Holy Family Hospital (Okhla, South Delhi), Mahanandan Hospital (Greater Noida), and the Renacare dialysis centres. This geographical spread ensures accessibility for patients from East Delhi, South Delhi, Noida, Greater Noida, and Ghaziabad.
Unlike models where patients see different doctors at different stages, Dr. Bhatt provides continuity from the initial CKD diagnosis through dialysis management, transplant evaluation, peri-operative nephrology care, and lifelong post-transplant follow-up. This single-physician continuity minimises handoff errors and builds deep patient-doctor trust.
Max Super Speciality Hospital, Patparganj — A 500+ bed NABH-accredited facility in East Delhi with a dedicated transplant wing, advanced immunology lab, and 24/7 transplant coordinator. One of the highest-volume transplant centres in the NCR.
Holy Family Hospital, Okhla — A trusted institution in South Delhi with over five decades of service. Its nephrology and urology departments have a long track record of successful transplants, supported by experienced anaesthesia and critical care teams.
Mahanandan Hospital, Greater Noida — A 250-bed super-speciality hospital providing access to advanced nephrology services for patients in the Noida–Greater Noida corridor, reducing the need to travel into congested Central Delhi.
Renacare Centres — Dr. Bhatt's affiliated dialysis centres across Delhi NCR provide maintenance haemodialysis for patients awaiting transplant, post-transplant dialysis support in cases of delayed graft function, and outpatient nephrology clinics for pre- and post-transplant care.
Use our AI-powered tools to understand your kidney health better before your consultation.